Sun Pharma Advanced Research Company Ltd
company logo

Sun Pharma Advanced Research Company Ltd

Pharmaceuticals
Mid Cap

-

- (0%)


Sun Pharma Advanced Research Company Ltd Performance

-

-

-

-


-

-

-

-

-

Sun Pharma Advanced Research Company Ltd Fundamentals

7,668.45Cr

-

61.42

0.17

-

-%

3.85

i buttonClick here to know more about Fundamentals

Sun Pharma Advanced Research Company Ltd Financials

Sun Pharma Advanced Research Company Ltd Financialsright-arrow

Sun Pharma Advanced Research Company Ltd Shareholding Pattern

Sun Pharma Advanced Research Company Ltd Delivery and Volume

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product development for global markets. They undertake projects in research and technology for new chemical ent

-

2006

SPARC

NameDesignation
T RajamannarDirector
Sudhir V ValiaDirector
Bhavna DoshiIndependent Director
Ferzaan EngineerIndependent Director
Robert SpiegelIndependent Director
Dilip S ShanghviChairman (Non-Executive)
News and Events...

Similar Stocks

What's Trending

Sun Pharma Advanced Research Company Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Sun Pharma Advanced Research Company Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Sun Pharma Advanced Research Company Ltd's share price is ₹235.9 as of 2024-07-14.
Sun Pharma Advanced Research Company Ltd's P/E ratio is - times as of 2024-07-14.
Sun Pharma Advanced Research Company Ltd's most recent financial reports indicate a price-to-book ratio of 61.42, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Sun Pharma Advanced Research Company Ltd's market capitalization is ₹7668.45 Cr as on 2024-07-14.
The current financial records of Sun Pharma Advanced Research Company Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Sun Pharma Advanced Research Company Ltd's most recent financial filings, the company has a total asset value of ₹164.06, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Sun Pharma Advanced Research Company Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Sun Pharma Advanced Research Company Ltd's 52-week high and low as of 2024-07-14 are ₹241.55 and ₹235, respectively.